We are live on ! Find out more
GNLX icon

Genelux

78 hedge funds and large institutions have $39.6M invested in Genelux in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

17,100% more call options, than puts

Call options by funds: $344K | Put options by funds: $2K

2,100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

37% more funds holding

Funds holding: 5778 (+21)

27% more capital invested

Capital invested by funds: $31.3M → $39.6M (+$8.39M)

4.26% more ownership

Funds ownership: 19.72%23.97% (+4.3%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
78
Holders Change
+21
Holders Change %
+36.84%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
22
Increased
20
Reduced
12
Closed
1
Calls
$344K
Puts
$2K
Net Calls
+$342K
Net Calls Change
+$140K

GNLX Hedge Fund Activity: Q4 2025 in Review

78 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Genelux (GNLX) for Q4 2025, worth a combined $39.6M — up 27% from $31.3M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new GNLX positions and 1 closed out — a net gain of 21 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $886K. The largest seller was Renaissance Technologies, cutting an estimated $215K.

  • 78 institutional investors held Genelux (GNLX) as of Q4 2025, up from 57 in Q3 2025.
  • Funds reported $39.6M of Genelux stock for Q4 2025, up 27% quarter-over-quarter.
  • 22 funds opened new Genelux positions in Q4 2025 and 1 closed out, a net change of +21 holders.
  • The largest Genelux buyer in Q4 2025 was Susquehanna International Group, an estimated $886K added.
  • The largest Genelux seller in Q4 2025 was Renaissance Technologies, an estimated $215K sold.

Based on aggregated 13F filings for Q4 2025.